Inj aval alfa-nqpt 4mg
Products billed under this code include Nexviazyme.
Payment limit per 4 MG, by effective quarter, 3Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J0219
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Nexviazyme | Genzyme Corporation | 58468-0426-01 | 25 | $2,095.40 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $83.816 | −$0.129 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted September 17, 2026 |
| 3Q26 | $83.945 | +$2.741 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted September 15, 2026 |
| 2Q26 | $81.204 | −$0.092 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted September 15, 2026 |
| 1Q26 | $81.296 | +$0.385 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted September 15, 2026 |
| 4Q25 | $80.911 | +$0.159 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted September 8, 2026 |
| 3Q25 | $80.752 | +$2.935 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted March 10, 2026 |
| 2Q25 | $77.817 | −$0.044 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted March 10, 2026 |
| 1Q25 | $77.861 | +$0.109 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted December 19, 2025 |
| 4Q24 | $77.752 | +$0.152 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted June 11, 2025 |
| 3Q24 | $77.60 | +$1.604 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted June 11, 2025 |
| 2Q24 | $75.996 | −$0.021 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted March 11, 2025 |
| 1Q24 | $76.017 | +$0.385 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted December 19, 2024 |
| 4Q23 | $75.632 | +$0.594 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted October 10, 2024 |
| 3Q23 | $75.038 | +$2.586 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted June 5, 2024 |
| 2Q23 | $72.452 | −$0.054 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted February 23, 2024 |
| 1Q23 | $72.506 | −$0.062 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted December 6, 2023 |
| 4Q22 | $72.568 | −$0.113 | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted June 22, 2023 |
| 3Q22 | $72.681 | – | 4 MG | Inj aval alfa-nqpt 4mg | v1, posted June 9, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023